Mottola Frank sold SUPN

March 9, 2026 · Form 4 insider transaction

Mottola Frank sold 1,623 shares of Supernus Pharmaceuticals, Inc. at $53.65 per share, a transaction worth $87.1K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.